Glymipril-MV 2 Tablet ER
Glymipril-MV 2 Tablet ER
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Ozomet-VG2 Tablet SR
Ozone Pharmaceuticals Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹92
that's 68% off!
About This Medicine
Product description & overview
Glymipril-MV 2 Tablet ER: A Comprehensive Diabetes Management Solution
Glymipril-MV 2 Tablet ER is a once-daily combined oral medication specifically designed to effectively manage type 2 diabetes. This formulation includes three key ingredients:
* Glimepiride (2mg): A sulfonylurea that stimulates insulin secretion, reducing blood glucose levels.
* Metformin (500mg): A biguanide used for improving insulin sensitivity and lowering glucose production in the liver.
* Voglibose (0.2mg): A selective α-glucosidase inhibitor that slows down glucose absorption after meals.
This unique combination provides comprehensive control over blood sugar, promoting healthy glycemic management. Glymipril-MV 2 Tablet ER is highly effective and suitable for adults with type 2 diabetes who require a convenient once-daily treatment option.
Important Note: This medication should only be taken under the guidance of a qualified healthcare professional. The dosage and specific instructions may vary depending on individual needs and medical history. Consult your doctor or pharmacist for further information before initiating or adjusting any medication regimen.
Active composition
Glimepiride 2 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glymipril-MV 2 Tablet ER.
High Risk
Pregnancy
Glymipril-MV 2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glymipril-MV 2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glymipril-MV 2 Tablet ER may be needed. Please consult your doctor. Glymipril-MV 2 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glymipril-MV 2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glymipril-MV 2 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glymipril-MV 2 Tablet ER is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glymipril-MV 2 Tablet ER
Products matching your search
Freego Granules
Freego Granules
Grandem Syrup
Grandem Syrup
Floxogril-O 500 Tablet
Floxogril-O 500 Tablet
Migarid 5 Tablet
Migarid 5 Tablet
Migon Tablet
Migon Tablet
Luna 10mg Tablet
Luna 10mg Tablet
Elicia 8 Tablet
Elicia 8 Tablet
Migrafree Tablet